ALNY : Alnylam Pharmaceuticals stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-03-14 |
|---|---|---|---|---|
| 2025 | $256.37 | $224.79 | $296.11 | 6.04% |
| 2026 | $241.97 | $219.11 | $279.32 | 0.09% |
| 2027 | $205.06 | $161.45 | $292.95 | -15.18% |
| 2028 | $171.51 | $112.55 | $226.75 | -29.06% |
| 2029 | $159.23 | $97.93 | $211.65 | -34.14% |
| 2030 | $142.83 | $106.58 | $188.41 | -40.92% |
| 2031 | $241.25 | $126.67 | $340.0 | -0.21% |
| 2032 | $354.08 | $343.08 | $381.98 | 46.46% |
| 2033 | $416.69 | $401.93 | $427.74 | 72.35% |
| 2034 | $457.74 | $435.32 | $465.75 | 89.34% |
| 2035 | $466.28 | $466.03 | $466.59 | 92.87% |
The 34 Wall Street analysts offering Alnylam Pharmaceuticals stock forecast in the last 6 months have average price target of
$332.24 with a high forecast of $500.0 and a low forecast of $220.0.
The average Alnylam Pharmaceuticals stock forecast represents a 37.43%
increase from the last price of $241.759994506836.
For Alnylam Pharmaceuticals stock forecast for 2025, 9 predictions are offered for each month of 2025 with average Alnylam Pharmaceuticals stock
forecast of $256.37, a high forecast of $296.11, and a low forecast of $224.79.
The average Alnylam Pharmaceuticals stock forecast 2025 represents a 6.04%
increase from the last price of $241.759994506836.
For Alnylam Pharmaceuticals stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Alnylam Pharmaceuticals stock
forecast of $241.97, a high forecast of $279.32, and a low forecast of $219.11.
The average Alnylam Pharmaceuticals stock forecast 2026 represents a 0.09%
increase from the last price of $241.759994506836.
For Alnylam Pharmaceuticals stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Alnylam Pharmaceuticals stock
forecast of $171.51, a high forecast of $226.75, and a low forecast of $112.55.
The average Alnylam Pharmaceuticals stock forecast 2028 represents a -29.06%
decrease from the last price of $241.759994506836.
For Alnylam Pharmaceuticals stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Alnylam Pharmaceuticals stock
forecast of $142.83, a high forecast of $188.41, and a low forecast of $106.58.
The average Alnylam Pharmaceuticals stock forecast 2030 represents a -40.92%
decrease from the last price of $241.759994506836.
For Alnylam Pharmaceuticals stock forecast 2031, 12 predictions are offered for each month of 2031 with average Alnylam Pharmaceuticals stock
forecast of $241.25, a high forecast of $340.0, and a low forecast of $126.67.
The average Alnylam Pharmaceuticals stock forecast 2031 represents a -0.21%
decrease from the last price of $241.759994506836.
For Alnylam Pharmaceuticals stock forecast for 2035 (10 year), 3 predictions are offered for each month of 2035 with average Alnylam Pharmaceuticals stock
forecast of $466.28, a high forecast of $466.59, and a low forecast of $466.03.
The average Alnylam Pharmaceuticals stock forecast 2035 represents a 92.87%
increase from the last price of $241.759994506836.
Please, see more forecasts below.
ALNY : Alnylam Pharmaceuticals stock forecast by Wall Street Analysts
The average Alnylam Pharmaceuticals stock forecast from last 6 month is $332.24, and this show a 3.58% increase in average from the prior price target of the each prediction. Also, this average forecast of $332.24 represents a 18.45% increase from the past average forecast of $280.5, 6 months ago from 40 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-03-11 | JP Morgan | $272.0000 | $280.0000 | Neutral |
| 2025-02-26 | Needham | $320.00 | $320 | Buy |
| 2025-02-26 | Chardan Capital | $300.00 | $300.00 | Buy |
| 2025-02-26 | RBC Capital | $310.0000 | $310 | Outperform |
| 2025-02-25 | HC Wainwright & Co. | $400.0000 | $500.0000 | Buy |
| 2025-02-24 | HC Wainwright & Co. | $400.00 | $500.0000 | Buy |
| 2025-02-18 | Canaccord Genuity | $384.0000 | $385.0000 | Buy |
| 2025-02-14 | Morgan Stanley | $275.0000 | $284 | Equal-Weight |
| 2025-02-14 | Scotiabank | $310.00 | $300.0000 | Sector Outperform |
| 2025-02-14 | Needham | $320.00 | $320 | Buy |
| 2025-02-11 | RBC Capital | $300.00 | $300.0000 | Outperform |
| 2025-01-21 | RBC Capital | $300.00 | $300 | Outperform |
| 2025-01-13 | Needham | $320.00 | $320 | Buy |
| 2025-01-13 | HC Wainwright & Co. | $400.00 | $400 | Buy |
| 2025-01-07 | Bernstein | $314.0000 | $310.0000 | Outperform |
| 2024-11-18 | HC Wainwright & Co. | $400.0000 | $400 | Buy |
| 2024-11-18 | Piper Sandler | $296.0000 | $296 | Overweight |
| 2024-11-12 | Wolfe Research | Underperform | ||
| 2024-11-04 | HC Wainwright & Co. | $400.00 | $400.00 | Buy |
| 2024-11-01 | Needham | $320.00 | $320.00 | Buy |
| 2024-11-01 | Chardan Capital | $300.00 | $300.00 | Buy |
| 2024-11-01 | Canaccord Genuity | $366.00 | $384.0000 | Buy |
| 2024-11-01 | Barclays | $295.00 | $329.0000 | Overweight |
| 2024-11-01 | Scotiabank | $305.00 | $310.0000 | Sector Outperform |
| 2024-11-01 | RBC Capital | $300.00 | $300.00 | Outperform |
| 2024-11-01 | Raymond James | $275.0000 | $298 | Outperform |
| 2024-10-21 | TD Cowen | $282.00 | $371.0000 | Buy |
| 2024-10-18 | HC Wainwright & Co. | $400.00 | $400.00 | Buy |
| 2024-10-16 | Scotiabank | $305.0000 | Sector Outperform | |
| 2024-10-14 | B of A Securities | $307.00 | $314 | Buy |
| 2024-10-11 | Cantor Fitzgerald | $220.00 | $220.0000 | Neutral |
| 2024-10-11 | Chardan Capital | $300.0000 | $300 | Buy |
| 2024-10-10 | Needham | $320.00 | $320 | Buy |
| 2024-10-10 | RBC Capital | $300.00 | $300.00 | Outperform |
| 2024-09-19 | RBC Capital | $300.00 | $300.00 | Outperform |
| 2024-09-09 | Cantor Fitzgerald | $220.00 | $220.0000 | Neutral |
| 2024-09-04 | RBC Capital | $300.00 | $300.00 | Outperform |
| 2024-09-04 | B of A Securities | $295.00 | $307.0000 | Buy |
| 2024-08-30 | HC Wainwright & Co. | $400.00 | $400.00 | Buy |
| 2024-08-26 | JP Morgan | $248.00 | $280.0000 | Neutral |
| 2024-08-20 | HC Wainwright & Co. | $400.00 | $400.00 | Buy |
| 2024-08-16 | Goldman Sachs | $198.00 | $370.0000 | Buy |
| 2024-08-02 | Goldman Sachs | $174.0000 | $198 | Neutral |
| 2024-08-02 | RBC Capital | $265.00 | $300 | Outperform |
| 2024-08-02 | Wells Fargo | $207.00 | $233.0000 | Equal-Weight |
| 2024-08-02 | Raymond James | $242.0000 | $275.0000 | Outperform |
| 2024-08-02 | Citigroup | $291.00 | $342.0000 | Buy |
| 2024-08-02 | Barclays | $291.00 | $295.0000 | Overweight |
| 2024-08-02 | Canaccord Genuity | $357.00 | $366.0000 | Buy |
| 2024-08-02 | Needham | $275.00 | $320 | Buy |
| 2024-07-22 | Cantor Fitzgerald | $150.00 | $220.0000 | Neutral |
| 2024-07-12 | Morgan Stanley | $250.00 | $255 | Equal-Weight |
| 2024-07-08 | Canaccord Genuity | $283.00 | $357.0000 | Buy |
| 2024-07-03 | JP Morgan | $160.0000 | $248.0000 | Neutral |
| 2024-07-01 | Cantor Fitzgerald | $150.00 | $150.0000 | Neutral |
| 2024-06-28 | UBS | $253.0000 | $288.0000 | Buy |
| 2024-06-27 | Stifel | $215.0000 | $295 | Buy |
| 2024-06-27 | RBC Capital | $250.00 | $265 | Outperform |
| 2024-06-25 | Leerink Partners | $138.0000 | $159.0000 | Market Perform |
| 2024-06-25 | Citigroup | $227.00 | $291.0000 | Buy |
| 2024-06-25 | B of A Securities | $248.0000 | $295 | Buy |
| 2024-06-25 | TD Cowen | $260.0000 | $282.0000 | Buy |
| 2024-06-25 | Evercore ISI Group | $210.0000 | $260.0000 | Outperform |
| 2024-06-25 | Barclays | $236.00 | $291.0000 | Overweight |
| 2024-06-25 | RBC Capital | $235.00 | $250 | Outperform |
| 2024-06-25 | Wells Fargo | $161.00 | $207.0000 | Equal-Weight |
| 2024-06-25 | Morgan Stanley | $164.0000 | $250.0000 | Equal-Weight |
| 2024-06-24 | BMO Capital | $234.00 | $234 | Outperform |
| 2024-06-24 | HC Wainwright & Co. | $400.00 | $400.00 | Buy |
| 2024-06-24 | Needham | $200.00 | $275 | Buy |
| 2024-06-21 | Canaccord Genuity | $283.0000 | $283.0000 | Buy |
| 2024-05-07 | HC Wainwright & Co. | $395.0000 | $400.0000 | Buy |
| 2024-05-03 | Chardan Capital | $225.00 | $225.00 | Buy |
| 2024-05-02 | Needham | $200.0000 | Buy | |
| 2024-03-27 | BMO Capital | $234.00 | $234 | Outperform |
Alnylam Pharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-03-17 | $248.62 | 2.84% |
| 2025-03-18 | $254.70 | 2.45% |
| 2025-03-19 | $254.09 | -0.24% |
| 2025-03-20 | $260.27 | 2.43% |
| 2025-03-21 | $277.75 | 6.72% |
ALNY : Long term Alnylam Pharmaceuticals stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Apr. is $230.18 , for 2026 Mar. is $219.11 , for 2029 Mar. is $206.52 , for 2030 Mar. is $142.55 , for 2034 Mar. is $452.40 , and for 2035 Mar. is $466.03.
ALNY : Alnylam Pharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Apr. | $230.18 | -4.79% |
| 2025 May. | $224.79 | -2.35% |
| 2025 Jun. | $228.02 | 1.44% |
| 2025 Jul. | $238.45 | 4.57% |
| 2025 Aug. | $253.09 | 6.14% |
| 2025 Sep. | $264.26 | 4.41% |
| 2025 Oct. | $278.19 | 5.27% |
| 2025 Nov. | $294.22 | 5.76% |
| 2025 Dec. | $296.11 | 0.64% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $259.72 | -12.29% |
| 2026 Feb. | $230.80 | -11.14% |
| 2026 Mar. | $219.11 | -5.06% |
| 2026 Apr. | $227.86 | 3.99% |
| 2026 May. | $250.65 | 10.00% |
| 2026 Jun. | $235.21 | -6.16% |
| 2026 Jul. | $223.77 | -4.86% |
| 2026 Aug. | $225.25 | 0.66% |
| 2026 Sep. | $235.66 | 4.62% |
| 2026 Oct. | $250.42 | 6.27% |
| 2026 Nov. | $265.88 | 6.17% |
| 2026 Dec. | $279.32 | 5.06% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $292.95 | 4.88% |
| 2027 Feb. | $260.32 | -11.14% |
| 2027 Mar. | $222.18 | -14.65% |
| 2027 Apr. | $191.82 | -13.66% |
| 2027 May. | $172.26 | -10.20% |
| 2027 Jun. | $161.53 | -6.23% |
| 2027 Jul. | $161.45 | -0.05% |
| 2027 Aug. | $171.83 | 6.43% |
| 2027 Sep. | $187.42 | 9.07% |
| 2027 Oct. | $202.71 | 8.16% |
| 2027 Nov. | $214.48 | 5.80% |
| 2027 Dec. | $221.76 | 3.40% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $225.32 | 1.61% |
| 2028 Feb. | $226.17 | 0.38% |
| 2028 Mar. | $226.75 | 0.26% |
| 2028 Apr. | $223.57 | -1.41% |
| 2028 May. | $188.42 | -15.72% |
| 2028 Jun. | $150.74 | -20.00% |
| 2028 Jul. | $122.55 | -18.71% |
| 2028 Aug. | $112.55 | -8.16% |
| 2028 Sep. | $118.11 | 4.94% |
| 2028 Oct. | $134.11 | 13.55% |
| 2028 Nov. | $154.87 | 15.48% |
| 2028 Dec. | $174.96 | 12.97% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $190.44 | 8.85% |
| 2029 Feb. | $200.62 | 5.34% |
| 2029 Mar. | $206.52 | 2.94% |
| 2029 Apr. | $209.98 | 1.68% |
| 2029 May. | $211.65 | 0.79% |
| 2029 Jun. | $183.39 | -13.35% |
| 2029 Jul. | $152.22 | -17.00% |
| 2029 Aug. | $128.51 | -15.58% |
| 2029 Sep. | $116.31 | -9.50% |
| 2029 Oct. | $112.46 | -3.31% |
| 2029 Nov. | $100.79 | -10.37% |
| 2029 Dec. | $97.93 | -2.84% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $106.58 | 8.84% |
| 2030 Feb. | $123.42 | 15.80% |
| 2030 Mar. | $142.55 | 15.50% |
| 2030 Apr. | $159.90 | 12.17% |
| 2030 May. | $172.71 | 8.01% |
| 2030 Jun. | $180.81 | 4.69% |
| 2030 Jul. | $188.41 | 4.20% |
| 2030 Aug. | $163.07 | -13.45% |
| 2030 Sep. | $136.42 | -16.34% |
| 2030 Oct. | $118.29 | -13.29% |
| 2030 Nov. | $108.85 | -7.98% |
| 2030 Dec. | $112.91 | 3.73% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $126.67 | 12.19% |
| 2031 Feb. | $145.72 | 15.04% |
| 2031 Mar. | $166.92 | 14.55% |
| 2031 Apr. | $188.68 | 13.03% |
| 2031 May. | $210.86 | 11.76% |
| 2031 Jun. | $233.09 | 10.54% |
| 2031 Jul. | $255.84 | 9.76% |
| 2031 Aug. | $278.35 | 8.80% |
| 2031 Sep. | $299.04 | 7.43% |
| 2031 Oct. | $317.64 | 6.22% |
| 2031 Nov. | $332.21 | 4.59% |
| 2031 Dec. | $340.00 | 2.35% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $343.08 | 0.90% |
| 2032 Feb. | $345.38 | 0.67% |
| 2032 Mar. | $347.94 | 0.74% |
| 2032 Apr. | $350.75 | 0.81% |
| 2032 May. | $351.53 | 0.22% |
| 2032 Jun. | $351.51 | -0.01% |
| 2032 Jul. | $351.90 | 0.11% |
| 2032 Aug. | $352.30 | 0.11% |
| 2032 Sep. | $352.69 | 0.11% |
| 2032 Oct. | $355.28 | 0.73% |
| 2032 Nov. | $364.58 | 2.62% |
| 2032 Dec. | $381.98 | 4.77% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $401.93 | 5.22% |
| 2033 Feb. | $409.39 | 1.86% |
| 2033 Mar. | $408.06 | -0.32% |
| 2033 Apr. | $406.35 | -0.42% |
| 2033 May. | $413.05 | 1.65% |
| 2033 Jun. | $418.82 | 1.40% |
| 2033 Jul. | $421.16 | 0.56% |
| 2033 Aug. | $422.63 | 0.35% |
| 2033 Sep. | $423.18 | 0.13% |
| 2033 Oct. | $423.40 | 0.05% |
| 2033 Nov. | $424.52 | 0.26% |
| 2033 Dec. | $427.74 | 0.76% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $435.32 | 1.77% |
| 2034 Feb. | $445.13 | 2.25% |
| 2034 Mar. | $452.40 | 1.63% |
| 2034 Apr. | $455.96 | 0.79% |
| 2034 May. | $457.46 | 0.33% |
| 2034 Jun. | $459.67 | 0.48% |
| 2034 Jul. | $461.99 | 0.50% |
| 2034 Aug. | $463.64 | 0.36% |
| 2034 Sep. | $464.73 | 0.23% |
| 2034 Oct. | $465.29 | 0.12% |
| 2034 Nov. | $465.52 | 0.05% |
| 2034 Dec. | $465.75 | 0.05% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $466.22 | 0.10% |
| 2035 Feb. | $466.59 | 0.08% |
| 2035 Mar. | $466.03 | -0.12% |
Financial Data for Alnylam Pharmaceuticals stock
Frequently Asked Questions about Alnylam Pharmaceuticals stock forecast
Is Alnylam Pharmaceuticals a good long term stock?
From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2025 Apr. is $230.184535365222 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2026 Mar. is $219.107202234224 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2029 Mar. is $206.51922086822 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2030 Mar. is $142.546083177056 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock can be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2034 Mar. is $452.397254866974 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock can be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2035 Mar. is $466.026383314047
Is Alnylam Pharmaceuticals stock overvalued?
Alnylam Pharmaceuticals (ALNY) stock is expected to go DOWN . Therefore, AIPickup would say that Alnylam Pharmaceuticals (ALNY) stock is overvalued.
Will Alnylam Pharmaceuticals stock price go up?
No. The Alnylam Pharmaceuticals stock price forecast for 2026 Mar. is $219.107202234224
Is Alnylam Pharmaceuticals stock a good buy now?
Since closing price on 2025-03-14 is $241.759994506836 and forecast for 2026 Mar. is $219.11, Alnylam Pharmaceuticals stock is not a good 1 year investment.
14 Days Historical Data for Alnylam Pharmaceuticals stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| ALNY stock price for 2025-02-25 | $245.20 | $251.50 | $238.46 | $251.56 |
| ALNY stock price for 2025-02-26 | $243.86 | $246.72 | $243.45 | $251.60 |
| ALNY stock price for 2025-02-27 | $237.10 | $244.73 | $236.55 | $246.38 |
| ALNY stock price for 2025-02-28 | $246.75 | $236.50 | $236.50 | $249.34 |
| ALNY stock price for 2025-03-03 | $243.53 | $246.18 | $241.91 | $250.00 |
| ALNY stock price for 2025-03-04 | $242.93 | $241.09 | $238.42 | $244.67 |
| ALNY stock price for 2025-03-05 | $249.23 | $243.02 | $241.55 | $249.82 |
| ALNY stock price for 2025-03-06 | $248.13 | $244.57 | $244.57 | $252.84 |
| ALNY stock price for 2025-03-07 | $244.52 | $247.14 | $240.98 | $251.12 |
| ALNY stock price for 2025-03-10 | $233.07 | $241.62 | $232.84 | $244.33 |
| ALNY stock price for 2025-03-11 | $238.74 | $230.85 | $230.79 | $243.45 |
| ALNY stock price for 2025-03-12 | $242.43 | $241.57 | $240.39 | $246.37 |
| ALNY stock price for 2025-03-13 | $241.75 | $240.96 | $239.02 | $245.14 |
| ALNY stock price for 2025-03-14 | $241.76 | $241.51 | $239.53 | $244.04 |